Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes

References

• BiganzoliLMinisiniAAaproMDi LeoAChemotherapy for metastatic breast cancerCurr Opin Obstet Gynecol2004161374115128006
   PubMed Web of Science ®Google Scholar
• MezoGManeaMReceptor-mediated tumor targeting based on peptide hormonesExpert Opin Drug Deliv201071799619947889
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRDrug delivery systems: Entering the mainstreamScience200430356651818182215031496
   PubMed Web of Science ®Google Scholar
• DrummondDCMeyerOHongKKirpotinDBPapahadjopoulosDOptimizing liposomes for delivery of chemotherapeutic agents to solid tumorsPharmacol Rev19995169174310581328
   PubMed Web of Science ®Google Scholar
• ElbayoumiTATorchilinVPTumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in miceMol Pharm20096124625419049322
   PubMed Web of Science ®Google Scholar
• KakarSSJennesLExpression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non reproductive human tissuesCancer Lett199598157628529206
   PubMed Web of Science ®Google Scholar
• SchallyAVSzepeshaziKNagyAComaru-SchallyAMHalmosGNew approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogueCell Mol Life Sci20046191042106815112052
   PubMed Web of Science ®Google Scholar
• SchallyAVComaru-SchallyAMNagyAHypothalamic hormones and cancerFront Neuroendocrinol200122424829111587553
   PubMed Web of Science ®Google Scholar
• NagyASchallyAVTargeting of cytotoxic luteinizing hormone-releasing hormone (LH-RH) analogs to breast, ovarian, endometrial and prostate cancersBiol Reprod200573585185916033997
   PubMed Web of Science ®Google Scholar
• DharapSSQiuBWilliamsGCSinkoPSteinSMinkoTMolecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptidesJ Control Release2003911–2617312932638
   PubMed Web of Science ®Google Scholar
• NagyASchallyAVCytotoxic analogues of luteinizing hormone-releasing hormone (LH-RH): A new approach to targeted chemotherapyDrugs Fut200227359370
   Web of Science ®Google Scholar
• WestphalenSKotullaGKaiserFReceptor mediated anti-proliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell linesInt J Oncol20001751063106911029513
   PubMed Web of Science ®Google Scholar
• KrebsLJWangXPudavarHERegulation of targeted chemotherapy with cytotoxic luteinizing hormone-releasing hormone analogue by epidermal growth factorCancer Res200060154194419910945629
   PubMed Web of Science ®Google Scholar
• KakarSSJinHHongBEatonJWKangKALHRH receptor targeted therapy for breast cancerAdv Exp Med Biol200861428529618290339
   PubMed Web of Science ®Google Scholar
• FauldsDBalfourJAChrispPLangtryHDMitoxantrone: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancerDrugs19914134004491711446
   PubMed Web of Science ®Google Scholar
• DunnCJGoaKLMitoxantrone: A review of its pharmacological properties and use in acute nonlymphoblastic leukaemiaDrugs Aging1996921221478820798
   PubMed Web of Science ®Google Scholar
• UgwuSZhangAParmarMPreparation, characterization, and stability of liposome-based formulations of mitoxantroneDrug Dev Ind Pharm200531222322915773289
   PubMed Web of Science ®Google Scholar
• LiCCuiJLiYCopper ion-mediated liposomal encapsulation of mitoxantrone: The role of anions in drug loading, retention and releaseEur J Pharm Sci2008344–533334418573336
   PubMed Web of Science ®Google Scholar
• CuiJLiCWangLNi2+-mediated mitoxantrone encapsulation: Improved efficacy of fast release formulationInt J Pharm20093681–2243018973800
   PubMed Web of Science ®Google Scholar
• LiCCuiJWangCLipid composition and grafted PEG affect in vivo activity of liposomal mitoxantroneInt J Pharm20083621–2606618598745
   PubMed Web of Science ®Google Scholar
• KawanoKOnoseEHattoriYMaitaniYHigher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantroneMol Pharm2009619810419072653
   PubMed Web of Science ®Google Scholar
• BeuttlerJRothdienerMMüllerDFrejdFYKontermannRETargeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL)Bioconjug Chem20092061201120819435362
   PubMed Web of Science ®Google Scholar
• DharapSSWangYChandnaPTumor-specific targeting of an anticancer drug delivery system by LHRH peptideProc Natl Acad Sci U S A200510236129621296716123131
   PubMed Web of Science ®Google Scholar
• LeuschnerCKumarCSHanselWSoboyejoWZhouJHormesJLHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastasesBreast Cancer Res Treat200699216317616752077
   PubMed Web of Science ®Google Scholar
• SundaramSDurairajCKadamRKompellaUBLuteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapyMol Cancer Ther2009861655166519509261
   PubMed Web of Science ®Google Scholar
• SaadMGarbuzenkoOBBerEReceptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging?J Control Release200813010711418582982
   PubMed Web of Science ®Google Scholar
• QinYSongQGZhangZROvarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vivo distribution in nude miceArzneimittelforschung2008581052953419025064
   PubMed Web of Science ®Google Scholar
• AllenTMSapraPMoaseEUse of the post-insertion method for the formation of ligand-coupled liposomesCell Mol Biol Lett20027388989412378272
   PubMed Web of Science ®Google Scholar
• MoreiraJNIshidaTGasparRAllenTMUse of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicityPharm Res200219326526911934232
   PubMed Web of Science ®Google Scholar
• DeryckeASDe WittePATransferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomesInt J Oncol200220118118711743662
   PubMed Web of Science ®Google Scholar
• JohnsonJLAhmadAKhanSImproved liquid chromatographic method for mitoxantrone quantification in mouse plasma and tissues to study the pharmacokinetics of a liposome entrapped mitoxantrone formulationJ Chromatogr B Analyt Technol Biomed Life Sci20047991149155
   Web of Science ®Google Scholar
• ElbayoumiTATorchilinVPTumor-targeted immunoliposomes for delivery of chemotherapeutics and diagnosticsJ Pharm Innov200835158
   Google Scholar
• AllenTMBrandeisEHansenCBKaoGYZalipskySA new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cellsBiochim Biophys Acta199512372991087632714
   PubMed Web of Science ®Google Scholar
• RegevRYeheskely-HayonDKatzirHEytanGDTransport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanismBiochem Pharmacol200570116116915919056
   PubMed Web of Science ®Google Scholar
• LiCCuiJWangCEncapsulation of mitoxantrone into pegylated SUVs enhances its antineoplastic efficacyEur J Pharm Biopharm200870265766518582570
   PubMed Web of Science ®Google Scholar
• YamauchiMTsutsumiKAbeMUosakiYNakakuraMAokiNRelease of drugs from liposomes varies with particle sizeBiol Pharm Bull200730596396617473443
   PubMed Web of Science ®Google Scholar
• NagyASchallyAVArmatisPCytotoxic analogues of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolino-doxorubicin, a derivative 500–1000 times more potentProc Natl Acad Sci U S A19969314726972738692981
   PubMed Web of Science ®Google Scholar
• RothADrummondDCConradFAnti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cellsMol Cancer Ther20076102737274617938267
   PubMed Web of Science ®Google Scholar
• CollinsDMaxfieldFHuangLImmunoliposomes with different acid sensitivities as probes for the cellular endocytic pathwayBiochim Biophys Acta1989987147552597686
   PubMed Web of Science ®Google Scholar
• KimMJLeeHJLeeIAPreparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomesArch Pharm Res200831453954618449514
   PubMed Web of Science ®Google Scholar